Successful Dartmouth TB Vaccine Moves Forward After Phase 2 Trial
September 30, 2020
September 30, 2020
DARTMOUTH, New Hampshire, Sept. 30 (TNSRes) -- The Dartmouth College Geisel School of Medicine issued the following news release on Sept. 29:
Results from the Phase 2 trial of the DAR-901 tuberculosis (TB) vaccine were announced today by investigators at Dartmouth's Geisel School of Medicine and published in the journal Vaccine. The three-year trial was conducted among 650 adolescents in Tanzania, a nation with high rates of TB infection, and showed that the vaccine was safe an . . .
Results from the Phase 2 trial of the DAR-901 tuberculosis (TB) vaccine were announced today by investigators at Dartmouth's Geisel School of Medicine and published in the journal Vaccine. The three-year trial was conducted among 650 adolescents in Tanzania, a nation with high rates of TB infection, and showed that the vaccine was safe an . . .